Culley Brian M - Insider Non-Derivative Transactions at Lineage Cell Therapeutics, Inc. (LCTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Culley Brian M's relationship to Lineage Cell Therapeutics, Inc. (LCTX) is Director,Officer (President and CEO), and currently has 157,648 shares of Common Shares, no par value, and 222,469 shares of Common Shares.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LCTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Culley Brian M - Insider Non-Derivative Transactions of LCTX Common Shares, no par value

Culley Brian M - Insider Non-Derivative Transactions of LCTX Common Shares

Culley Brian M - Insider Non-Derivative Transactions at LCTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	F -- (Common Shares)	334	1.68	222135
Dec 20, 2025	Acquisition -- (Common Shares)	8925	0	222469
Feb 12, 2025	F -- (Common Shares)	12547	0.65	213544
Feb 12, 2025	M -- (Common Shares)	31249	0	226091
Nov 22, 2024	P -- (Common Shares)	40000	0.6	194842
May 25, 2024	P -- (Common Shares)	10000	1.05	154842
Feb 12, 2024	F -- (Common Shares, no par value)	12806	1.08	144842
Feb 12, 2024	M -- (Common Shares, no par value)	31249	0	157648
Feb 12, 2023	F -- (Common Shares, no par value)	12744	1.35	126399
Feb 12, 2023	M -- (Common Shares, no par value)	31249	0	139143